Luye Pharma Group Ltd. (FRA:LUP)
Germany
· Delayed Price · Currency is EUR 0.3280
-0.0020 (-0.61%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Oncology Drugs | 2.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Drugs Growth | -3.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular System Drugs | 1.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular System Drugs Growth | -3.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System Drugs | 1.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System Drugs Growth | -6.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Alimentary Tract and Metabolism Drugs | 421.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Alimentary Tract and Metabolism Drugs Growth | -15.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 341.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 63.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| China | 5.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -3.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union | 636.08M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union Growth | 27.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 376.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | -23.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 219.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | -8.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|